Safety and Efficacy Study of Botulinum Toxin for the Treatment of Glabellar Frown Lines
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to evaluate the efficacy in wrinkle reduction of a
single treatment of three different doses of botulinum toxin compared to placebo, in the
treatment of moderate to very severe glabellar frown lines.
Phase:
Phase 2
Details
Lead Sponsor:
Q-Med AB
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA